XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 7/31/2012 6:26:34 PM : Underperform Start Price: $7.93 XNPT Score: -4.75

Overpriced right now

Featured Broker Partners


Advertisement